Search results for " CGMP"

Article Understanding Validation and Technical Transfer, Part I
The 1978 CGMP regulations (4) discussed validation in terms of automatic, mechanical, and electronic equipment (21 CFR § 211.68), validation of supplier’s test results for components, drug product con…

Article The New World of Biopharmaceutical Manufacturing
An initial focus on small-batch clinical trials has expanded to full-scale cGMP commercial production. More recently, drug manufacturers are using fully closed systems to make multiple drugs in large …

Article Unifying Continuous Biomanufacturing Operations
Integrated continuous bioprocessing is already regularly being achieved in small research labs, according to Bonham-Carter, but has not yet made its mark in commercial, cGMP environments (8). Pr…

Article Speed and Flexibility Are Dual Goals for Biopharma Operations
The facilities, built in partnership with Cytiva, offer cGMP manufacturing based on mammalian cell culture technologies to meet customer demand for Phase II/III clinical trials. In addition, the singl…

Article Real Time Continuous Microbiological Monitoring
Laser-induced fluorescence, a rapid microbiology method for real-time airborne particle and microbial monitoring, enhances sterility assurance in pharmaceutical manufacturing. By Claudio Denoya …

Article FDA Releases Draft Guidance on Emerging Manufacturing Technology
The agency launched an initiative in 2002 entitled Pharmaceutical CGMPs for the 21st Century: A Risk-Based Approach. One of the main goals of the 2002 initiative is encouraging new technology advances…

Article GMP Challenges for Advanced Therapy Medicinal Products
56: Application of Phase-Appropriate Quality Systems and CGMP for the Development of Therapeutic Protein Drug Substance (Bethesda, US, 2012). About the author: Sean Milmo is a freelance write…

Article Modular Manufacturing Platforms for Biologics
The continuous processing skid was prefabricated in Belgium, integrated into a portable cGMP pod that had been prefabricated in College Station, TX, and then re-assembled into Pfizer’s gray warehouse …

Article Continuous Manufacturing: A Changing Processing Paradigm
FDA support for quality improvements FDA has been a strong supporter of continuous processing as early as 2004 when it released Pharmaceutical cGMPs for the 21st Century–A Risk-Based Approach. In …

Article Challenges and Trends in Biopharma Facility Design
We have designed a turnkey modular factory, KUBio, which offers a monoclonal antibody manufacturing factory within 14-18 months and is pre-designed to support achieving cGMP requirements. For biop…

Previous PageNext Page